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Abstract
In mammals, the circadian clock relies on interlocked feedback loops involving clock genes and their protein products. Post-
translational modifications control intracellular trafficking, functionality and degradation of clock proteins and are keys to
the functioning of the clock as recently exemplified for the F-Box protein Fbxl3. The SCF
Fbxl3 complex directs degradation of
CRY1/2 proteins and Fbxl3 murine mutants have a slower clock. To assess whether the role of Fbxl3 is phylogenetically
conserved, we investigated its function in the sheep, a diurnal ungulate. Our data show that Fbxl3 function is conserved and
further reveal that its closest homologue, the F-Box protein Fbxl21, also binds to CRY1 which impairs its repressive action
towards the transcriptional activators CLOCK/BMAL1. However, while Fbxl3 appears to be ubiquitously expressed, Fbxl21
expression is tissue-specific. Furthermore, and in sharp contrast with Fbxl3, Fbxl21 is highly expressed within the
suprachiasmatic nuclei, site of the master clock, where it displays marked circadian oscillations apparently driven by
members of the PAR-bZIP family. Finally, for both Fbxl3 and Fbxl21 we identified and functionally characterized novel splice-
variants, which might reduce CRY1 proteasomal degradation dependent on cell context. Altogether, these data establish
Fbxl21 as a novel circadian clock-controlled gene that plays a specific role within the mammalian circadian pacemaker.
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Introduction
Endogenous circadian clocks generate rhythms of physiology
and behaviour, and are synchronised to the environment through
rhythmical stimuli, principally the light/dark cycle. These clocks
allow organisms to anticipate and adapt to cyclical changes in
environmental favourability.
In mammals, the circadian clock relies on interlocked feedback
loops in which a heterodimer of transcription factors, CLOCK/
BMAL1 (CLK/BM1), drives transcription of Period1-3 (Per1-3) and
Cryptochrome1-2 (Cry1-2) genes through E-Box cis-elements. The
PER1-3 and CRY1-2 proteins then act as transcriptional
inhibitors of CLK/BM1. Apart from Per1-3 and Cry1-2, the
CLK/BM1 heterodimer acts on other genes, some of which are
themselves clock components, such as the orphan nuclear
receptors Rev-erb a or Ror a, while others are outputs from the
clock, resulting in the regulation of cell- and tissue-specific
processes [1–3]. The orphan nuclear receptors of the ROR and
REV-ERB families act on DNA motifs known as ROREs to
control rhythmic transcription of the Bmal1 gene, with activating
and repressive action, respectively [4–7]. Other ancillary inter-
locked feedback loops, such as that through which REV-ERBs and
RORs impinge on the transcriptional control of Rev-erb alpha [8–
10] or that closed by the clock-controlled PAR-bZIP proteins
through D-Boxes [11–13] add to the robustness of the clock
mechanism [14].
Patterns of rhythmical transcription depend heavily on post-
translational mechanisms operating within the circadian clock
[3,15–17]. Post-translational modifications of clock proteins include
phosphorylation [16], SUMOylation [18] or acetylation [19], most
of which are induced upon formation of heterodimers or larger
protein complexes. These processes control intracellular trafficking
ofclockproteins,theirfunctionalityandultimatelytheirdegradation.
A timely orchestrated degradation of clock proteins is
indispensable to the proper functioning of the clock as illustrated
by the recently uncovered role for the F-Box protein Fbxl3. In
mammals, the F-Box protein family comprises about 40 members,
which direct ubiquitination and proteasome-mediated degradation
of specific proteins through SCF (Spk/Cullin/F-Box protein) E3
ubiquitin ligase complex [20–22]. Accordingly, the SCF
Fbxl3
complex was recently shown to direct degradation of CRY1 and
CRY2 proteins, with mutations in Fbxl13 leading to a slowed
circadian clock in mice [23–25].
We sought to test whether the regulating effect of Fbxl3 was
conserved in the diurnal sheep and investigate whether its closest
homologue, Fbxl21 [26], is also involved in circadian function.
Results and Discussion
Ovine orthologues of Fbxl3 and Fbxl21
Cloning of ovine Fbxl3 generated a full-length (oFbxl3fl,
GenBank EF643523) coding sequence (cds) of 1290 nucleotides
PLoS ONE | www.plosone.org 1 October 2008 | Volume 3 | Issue 10 | e3530(nt), giving a protein of 429 amino acids (Fig 1A/B). Overall
sequence homologies to bovine, murine and human Fbxl3 were all
.95%, with 100% amino acid conservation in the region 332–
385, which encodes a CRY binding domain (CBD, Fig 1G).
Additionally, we isolated a truncated in-frame splice-variant
(oFbxl3sv, GenBank EF643524), in which nt 209 to 354 are
deleted (Fig 1A). Alternative splicing (AS) describes the process of
splicing exons of pre-mRNAs in different arrangements and
drastically expands the potential repertoire of protein variants [27–
30]. Since there is an evolutionary trend towards increased AS in
complex organisms, this mechanism may resolve the paradoxical
lack of increasing number of expressed genes in increasingly
complex eukaryotic organisms [27–28]. It appears that AS is
widespread since recent large-scale analyses indicate that as much
as 70–80% of genes in mammals are subject to AS [29,31]. In the
case of oFbxl3sv, AS spares the open reading frame but leads to a
truncation of the F-box motif in the protein (Fig 1B, Pfam score
diminished by 2.10
4-fold compared to oFbxl3fl), while the CBD is
left intact. Such a protein is therefore predicted to have intact
CRY binding while coupling with the proteasome degradation
pathway may be impaired. We designed primers to encompass the
predicted AS region (Fig 1A, O47C/O48C), or to select for the
splice-variant (oFbxl3sv) (Fig 1A, O51C/O52C, see M&M for
oligos sequences and details), and screened for Fbxl3 expression in
ovine tissues (Fig 1C). This clearly demonstrates that both
oFbxl3fl and oFbxl3sv are ubiquitously expressed.
Sequence phylogeny analysis shows that Fbxl21 is the closest
relative of Fbxl3 [26]. We therefore cloned a full-length cds for
ovine Fbxl21 (oFbxl21fl, GenBank EU239380). This yielded a
1305 nt sequence giving a protein of 434 amino acids with a
greater degree of inter-species divergence than was the case for
Fbxl3 (94, 84 and 82% homology with bovine, mouse and human
Fbxl21 respectively, Fig 1D). Fbxl21 appears to be a paralogue of
Fbxl3 that arose through gene duplication relatively recently;
indeed, unlike Fbxl3, no clear orthologue of Fbxl21 could be
identified in fish genomes (Ensembl database). Within the region
corresponding to the CBD of Fbxl3, amino acid identity to
mFbxl21 was only 79% although most substitutions were either
conservative or semi-consevative (Fig 1D/E and G). Here too, a
splice-variant (oFbxl21sv, GenBank EU239381) was isolated. This
splice-variant lacks 70 nt, is therefore out of frame (Fig 1D/E; fs:
frame-shift) and presents an early stop-codon (TGA). This
Figure 1. Cloning and mRNA distribution of ovine Fbxl3 and Fbxl21. A/D. Schematics depicting the cds of mRNA of Fbxl3 and Fbxl21,
respectively. Primers used for RT-PCR are indicated. Note that Fbxl3sv is an in-frame splice-variant while Fbxl21sv is an out-of-frame splice-variant (fs
for frame-shift) with an early stop-codon (TGA, nt 489). B/E. Schematics depicting the proteins encoded by the Fbxl3 and Fbxl21 transcripts,
respectively. Note that part of F-Box motif of Fbxl21sv is disrupted due to the splicing event while the CBD is spared. Note also that Fbxl21sv is a short
protein product of 171 amino acids with the last 8 amino acids (indicated in green) differing from Fbxl21fl due to the AS event. The F-Box motif is left
intact but Fbxl21sv does not have a CBD. C. RT-PCR for Fbxl3 on central and peripheral tissues sampled at ZT4. Co-amplification of a CKId fragment
was used as an internal positive control (oCKId, GenBank EF643522), absence of cDNA in the PCR mix as a negative control. Upper panel: screening
with O47C/O48C primers. Lower panel: screening with O51C/O52C primers clarifies the tissue distribution of Fbxl3sv. F. RT-PCR for Fbxl21 on central
and peripheral tissues sampled at ZT4. G. Sheep - mouse amino acid conservation within the CBD of Fbxl3 and Fbxl21. Residues associated with the
Afterhours (Afh) and Overtime (Ovtm) Fbxl3 mutants are highlighted in red. Blue shading indicates residues that differ in at least one of the four
sequences. Star, two dots and one dot indicate identical, conservative and semi-conservative substitutions, respectively. Pfam scores for F-box motifs:
Fbxl3fl 3.9e
209, Fbxl3sv 2.1e
205, Fbxl21fl and Fbxl2sv 6.5e
211.
doi:10.1371/journal.pone.0003530.g001
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leaving the F-box motif intact but lacking the CBD (Fig 1D/E).
Such a protein is therefore unlikely to bind CRY proteins while
coupling with the proteasome degradation pathway would be
retained. As for oFbxl3, we designed primers (O49C/O50C) to
determine the tissue distribution of oFbxl21fl and oFbxl21sv. This
revealed that Fbxl21 exhibited much more varied levels of
expression between tissues than Fbxl3, with maximal expression
in the adenohypophysis, hypothalamus and pineal (all neuroen-
docrine structures associated with timing and homeostasis) and no
expression evident in liver, adrenal or white adipose tissue (WAT)
(Fig 1F). The truncated transcript, oFbxl21sv, was detected in all
tissues in which oFbxl21fl was also expressed. A similar
distribution pattern was observed when RNA were extracted
from animals sampled at either ZT4 (present data) or ZT15 (data
not shown) indicating that absence of detection of Fbxl21 in liver,
adrenal and WAT is unlikely due to a time-of-day effect on
sampling (see below).
Transcripts encoding truncated protein products such as
oFbxl21sv have long been considered as erroneous splicing events
but recent evidence indicates they may have specific functions
[27,30,32]. Strikingly, conservation in splice-variant isoforms
between mouse and human is very low, with estimates around
10–20% [28–29]. This might indicate meaningful evolutionary
differences or, alternatively, reveal that splice-variants are merely a
reflection of molecular noise generated by the splicing machinery
[28–30]. In this context it is noteworthy that the same in-frame
Fbxl3sv transcript characterized in the sheep is also present in the
mouse (data not shown). Furthermore, we cloned a novel splice-
variant for Fbxl21 in the mouse that encodes for a truncated
protein product of a sequence reminiscent to that of oFbxl21sv
(GenBank EU770600). These data demonstrate that AS is
commonplace in the F-box protein family as emphasized
elsewhere [26], which offers another putative layer of fine-tuning
in the circadian clock. Furthermore, the fact that oFbxl3fl and
oFbxl3sv are ubiquitously expressed while oFbxl21fl and
oFbxl21sv display a clear-cut tissue-specific distribution strength-
ens the view that circadian clocks among tissues might have
different characteristics, as previously suggested [7,33].
Fbxl3 and Fbxl21 physically associate with Cry1
We used co-immunoprecipitation assays to determine whether
sheep Fbxl3/21 orthologues bind to CRY1 in-vitro. We therefore
cloned a full-length cds for ovine Cry1 (oCry1, GenBank
EF494243) in a Flag-tagged expression vector while Fbxl3fl,
Fbxl3sv, Fbxl21fl and Fbxl21sv were cloned in Myc-tagged
expression constructs. These were co-transfected into COS7 cells
in different combinations, prior to co-immunoprecipitation with
beads coated with a-Myc antibodies followed by Western blotting
(WB) with a-Myc or a-Flag antibodies (WB, Fig 2A). Consistent
with data in the mouse [23,25], we observed pull-down of oCRY1
by oFbxl3fl. This was also observed for oFbxl3sv, as predicted by
the preservation of the CBD in this transcript. A similar pull-down
was observed for oFbxl21fl, but not for oFbxl21sv that lacks the
CBD. These findings confirm predictions and indicate that
interaction with CRY1 requires the CBD.
In spite of the sequence divergence between the Fbxl21 CBD of
sheep and mouse (Fig 1G), pull-down experiments using mFbxl21
instead of oFbxl21 demonstrate that the CRY1 binding ability is
intact (Fig 2B).
Differential effects of ovine Fbxl variants on CRY1 protein
degradation
We then assessed whether oFbxl proteins affect the degradation
kinetics of molecular clock components. For this purpose full-
length cds for orthologues of Clk (oClk, GenBank EU016223) and
Bm1 (oBm1, GenBank EF494245) were cloned in the sheep.
COS7 cells were co-transfected with oCry1, oBm1 and oClk in
combination with the three Fbxl constructs which co-immuno-
precipitated with oCRY1, and then treated with the protein
synthesis inhibitor cycloheximide (CHX, 25 mg/ml) for 0–8 h.
Proteins were extracted and relative levels were assessed by WB
(Fig 3A).
The Fbxl proteins had different effects on baseline oCRY1 and
oBM1 levels immediately prior to CHX treatment (t=0), but no
impact on those for oCLK (Fig 3B). Full-length oFbxl3 strongly
reduced baseline of oCRY1 levels while oFbxl21fl did not have any
clear effect on oCRY1 levels, in agreement with previous results (see
Fig 2A, input). Contrastingly, baseline levels of oCRY1 showed a
trend towards higher levels by co-transfection of oFbxl3sv, in-line
with the predicted impaired coupling to the proteasome degradation
pathway and suggestive of a dominant-negative effect.
To normalise for these differing baseline levels, data were
replotted as a fraction of t=0 values for each expression vector
combination (Fig 3C). Degradation rates in cells co-transfected
with empty vector (ev) served as controls. These data demonstrate
that only the rate of oCRY1 degradation is highly dependent on
co-transfection of oFbxl expression vectors (two-way ANOVA, the
value for the interaction treatment6time is indicated on the right
of Fig 3C). When compared to the ev control condition it was
clear that oFbxl3fl exerts the strongest degradation promoting
effect on CRY1 proteins (post-hoc test, p,0.01), reducing their
Figure 2. Ovine and murine Fbxl3 and Fbxl21 physically associate with oCry1. A. Extracts from COS7 cells co-transfected with Myc-Fbxl
and Flag-Cry1 expression vectors were submitted to immunoprecipitation (IP) with a-Myc beads followed by western-blotting (WB). The oCRY1
protein was readily co-purified with oFbxl3fl, oFbxl3sv and oFbxl21fl but not with oFbxl21sv. Note the low CRY1 levels in the input when Fbxl3fl was
present. Similar detection levels of IgG (from Myc antibodies) across all conditions demonstrate loading of comparable amounts of supernatant.
ev=empty expression vector. B. The use of similar methods demonstrates that the mouse Fbxl21 also interacts with oCRY1.
doi:10.1371/journal.pone.0003530.g002
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blockade. A qualitatively similar but quantitatively more modest
effect (non-significant, post-hoc test p,0.1) was seen for oFbxl21fl.
By contrast, degradation rates for oCRY1 (but not oCLK or
oBM1) in cells transfected with oFbxl3sv showed a trend towards
reduction compared to controls (non-significant, post-hoc test
p,0.1), confirming predictions that the truncated F-box motif in
this protein leads to a protein stabilising effect.
Collectively these data indicate that Fbxl21fl and Fbxl3sv, in
addition to Fbxl3fl, govern the kinetics of degradation of CRY1.
Fbxl3 and Fbxl21 modulate CRY1 suppression of CLK/
BM1 induced E-box transactivation
To investigate whetherthesedifferential effects onprotein stability
result in different clock gene function in vitro, we constructed a
luciferase reporter with the promoter region of the sheep Rev-erb a
gene (GenBank EF494248), a gene whose transcription is regulated
through circadian E-boxes, responsive to CLK/BM1 [1–3]. We
then performed further co-transfection experiments in which the
impact of the various Fbxl on oCRY1-dependent transcriptional
repression of oRev-erb a expression could be assessed.
Similarly to results obtained in the mouse [25], this approach
revealed that oCRY1 is a potent inhibitor of oCLK/oBM1-
induced oRev-erb a transactivation, reducing expression by
approximately 5-fold (Fig 4A). This repressive effect was
attenuated by approximately 75% upon co-transfection with
oFbxl3fl or oFbxl21fl, consistent with the oCRY1 degradation
promoting effects of these proteins. According to predictions,
oFbxl3sv and oFbxl21sv proteins failed to reduce the repressive
effects of oCRY1, likely due to the truncated F-box motif and lack
of the CBD, respectively.
A similar set of experiments was performed using previously
validated [34] murine clock components (mClk, mBm1, mCry1
and an mPer1-luc reporter gene construct). Akin to what is observed
for oFbxl21fl, mFbxl21fl is able to reverse mCRY1-induced
repression of mCLK/mBM1 transactivation (Fig 4B).
Rhythmical Fbxl21 expression is confined to the SCN
within the hypothalamus
Our RT-PCR screen showed that Fbxl3 is ubiquitously
expressed while Fbxl21 has a highly tissue-specific expression
pattern. We therefore wondered if Fbxl21 also shows localised
expression within the hypothalamus. To address this, we
performed radioactive in situ hybridisation in brain tissue from
sheep sampled at ZT 4-6 and mice sampled around the clock using
homologous probes. Remarkably, in the sheep hypothalamus we
observed strong labelling within the SCN, which harbours the
mammalian master clock, in a region overlapping with sites of
arginine vasopressin (Avp, GenBank EU045357) and vaso-active
intestinal polypeptide (Vip, GenBank EU016225) expression
Figure 3. Fbxl21 and Fbxl3 promote degradation of ovine
CRY1 and BM1. A. COS7 cells were transfected with oCry1, oBm1 and
oClk, and an oFbxl expression vector as indicated above each lane.
Extracts were made at the start of cycloheximide (CHX) treatment (t=0)
or 2 or 8 h later as indicated and protein levels assessed by WB.
Transfection conditions per well: 1 mg of oClock, 600 ng of oBmal1,
600 ng of each oFbxl/ev and 400 ng of oCry1. B. Quantitation of
baseline levels (t=0) of oCRY1, oBM1 or oCLK proteins. Data are
normalised to values observed in cells not transfected with any oFbxl
(ev). **: significantly lower density than for ev, p,0.01, One-way ANOVA
followed by Student-Newman-Keuls post-hoc test. C. Quantitation of
temporal decline in protein levels following the start of CHX treatment.
Data are expressed relative to t=0 values for each vector combination.
p values for the interaction (treatment6time, two-way ANOVA) are
given on the right. Data in B/C are mean6SEM of observations from 3
replicate experiments.
doi:10.1371/journal.pone.0003530.g003
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which showed relatively weak and diffuse labelling (Fig 5A).
Further experiments in mice confirmed this SCN-restricted
pattern of Fbxl21 expression, and demonstrated pronounced
diurnal and circadian expression rhythms, rising rapidly at the
start of the day (or ‘‘subjective day’’ in animals run into constant
darkness), and declining at the onset of the (subjective) night
(Fig 5B). In contrast, Fbxl3 was diffusely expressed in the SCN of
mice where it displayed no diurnal or circadian oscillation (data
not shown and Fig 5C), in-line with previous findings [24,25].
Representative hybridization images from brains of animals
sampled either in the beginning/middle of the day (ZT4) or
beginning/middle of the night (ZT16) are shown in Fig 5C.
These data suggest that Fbxl21 may be a clock-controlled gene
that plays a specific role in SCN pacemaker function.
Fbxl21 is a clock-controlled gene
The circadian pattern of Fbxl21 expression in the mouse SCN is
reminiscent of that seen for other genes whose expression is driven
by CLK/BM1 such as Per1 or Dbp. Analysis of the mFbxl21 gene
promoter revealed no canonical E-Box (CACGTG) but 11 E’
Boxes (CANNTG). Only 4 of these are conserved in the rat
promoter (Fig 6A, E’1–4). Interestingly we noticed a putative D-
Box element (Fig 6A), which is also conserved in the rat, human,
bovine, dog and chicken Fbxl21 gene promoters in spite of the very
poor sequence conservation between species (data not shown).
Such a response element is known to mediate transactivation by
members of the PAR-bZIP transcription factors family (DBP:
albumin D-site binding protein, GenBank EU293835; HLF:
Hepatic leukemia factor, Genbank EU293836 and TEF: thyro-
troph embryonic factor, GenBank EU293837) that are clock-
controlled genes and display strong circadian oscillation within the
SCN peaking early into the light phase [12–13]. We therefore
cloned a 1.3 kb fragment of the proximal mFbxl21 gene promoter
and used luciferase assays to assess transactivation by CLK/BM1
and the PAR-bZIP proteins (Fig 6B). This revealed modest (,2-
fold) transactivating effects of CLK/BM1 and DBP, and stronger
(4–7 fold) effects of HLF and TEF. The modest (n.s., p=0.08)
effect of DBP could be due to differences in binding affinities of the
various PAR-bZIP proteins towards this D-Box [35]. Alternative-
ly, transcriptional co-factors required for DBP might be missing in
this cell type.
Taken together, these data suggest that the rhythmic expression
of Fbxl21 in the mouse SCN derives from combined transactiva-
tion through E’boxes and a conserved D-Box element.
Conclusion
Altogether, these data indicate a broad conservation of
transcriptional and post-translational mechanisms of the circadian
clock between a nocturnal rodent and a diurnal ungulate and
identify Fbxl21 as a new clock component whose expression is
driven by the core-clock. The functional characterization of new
splice-variants also suggests that AS might be an important
mechanism to fine-tune the clock. This idea is also supported by
data for Bmal2 [34,36], Timeless [37] or the finding of a
temperature-dependent splicing of the Period gene in Drosophila
[38]. Since Fbxl21 directs degradation of CRY1 and displays
strong and specific rhythmic circadian expression within the
central pacemaker of the SCN, we suggest that Fbxl21 stands at a
crucial crossroads between activation and repression in central
clocking (Fig 7). Finally, the present data also raise the possibility
of functional redundancy between Fbxl3 and Fbxl21 in the SCN
akin to what was recently reported for Clock and Npas2 [39].
Future studies defining FBXL21 protein profiles within the SCN
and targeted deletion of the gene should help delineate further the
role of Fbxl21 in circadian timing.
Materials and Methods
Sheep tissue collection
Hypothalamic blocks for in-situ hybridisation and central tissue
samples were obtained from Blackface sheep killed at a local
Figure 4. Functional transcriptional effects of Fbxl3 and Fbxl21. A. oFbxl3 and oFbxl21 dose-dependently reverse oCRY1 inhibition of oCLK/
oBM1 induced transactivation of an oRev-erb a reporter construct. Transfection conditions per well: 100 ng of oClock, 100 ng of oBmal1, 100 ng of
oCry1, 100 or 200 ng of each Fbxl or ev, 50 ng of oRev-erb alpha promoter reporter, 50 ng of b-Gal reporter and/or necessary amount of empty vector
to make a final amount of 600 ng. B. mFbxl21 dose-dependently reverses mCRY1 inhibition of mCLK/mBM1 induced transactivation of an mPer1
reporter construct. Transfection conditions per well: 100 ng of mClock, 100 ng of mBmal1, 20 ng of oCry1, 100 or 200 ng of mFbxl21 or ev, 50 ng of
Per1 promoter reporter, 50 ng of b-Gal reporter and/or necessary amount of empty vector to make a final amount of 600 ng. Data in A/B are
mean6SEM of one triplicate representative from 3 replicate experiments. Different letters above bars indicate significantly different groups (p,0.05).
doi:10.1371/journal.pone.0003530.g004
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killed by the pneumatic captive bolt gun method carried out by a
licensed person. Peripheral tissues were sampled from Soay rams
killed by an overdose of barbiturate (Euthatal; Rhone Merieux,
Essex, UK) administered intravenously. All experiments were
performed in accordance with Home Office (UK) legislation and
approved by University of Edinburgh Local Ethics Committee.
Tissues were rapidly dissected out, frozen onto dry ice and kept at
280uC until sectioning or RNA extraction.
Mouse tissue collection
Adult male Swiss mice (Charles River, Lyon, France) were kept in
a 12-hlight/darkcycle (LD)or transferred to constant darkness(DD)
for 2 days. After mice were deeply anesthetized with isoflurane and
decapitated, brains were removed, frozen and cut in 20-mmc o r o n a l
sections at the level of the suprachiasmatic region. Five mice were
killed every 4 h throughout the LD cycle (expressed in zeitgeber
time, ZT0 being the time of lights on) or throughout the DD cycle
(expressed in circadian time, CT0 being defined as the projected
time of lights on). Experiments were performed in accordance with
the rulesoftheEuropeanCommitteeCouncildirectiveofNovember
24, 1986 (86/609/EEC) and the French Department of Agriculture
(license nu67–88 to E.C.).
Cloning
DNA extraction was done with a QIAamp DNA mini kit
(Qiagen). RNA extraction was performed using Tri-reagent
(Sigma) according to the manufacturer’s protocol, and cDNA
synthesis was carried out using a reverse transcription kit (Qiagen).
When sheep EST were not available, ClustalW alignments of
mammalian sequences were performed in order to identify
conserved regions suitable for primer design (primers from
MWG Biotech, Germany). PCR was done with Platinum Taq
Hifi (Invitrogen) according to the manufacturer’s protocol.
Following agarose gel electrophoresis, PCR fragments of the
expected sizes were extracted using a gel extraction kit (Qiagen)
and cloned in pGEM-T easy vector (Promega). Four to six positive
clones were sequenced (MWG, United Kingdom), and the
sequences deposited in GenBank. To generate expression
constructs, a second round of PCR was performed using primers
flanked by adequate restriction sites and the pGEM-T clone as
template. PCR fragments were extracted as described above,
digested by the adequate restriction enzymes, purified with a PCR
purification kit (Qiagen) and cloned in the expression vector
backbone. Two different expression vectors with either a Flag or a
5X-Myc tag were used. To generate promoter reporter constructs,
a strategy identical to that described above was applied. All
fragments were cloned into the pGL3 basic backbone (Promega)
digested with the appropriate restriction enzymes. Sequencing was
performed to check accuracy of the re-amplified cloned fragments.
All primer sequences and constructs are available upon request.
Cell culture, transfection and luciferase assay
COS-7 cells were grown in Dulbecco’s modified Eagle’s
medium supplemented with 10% fetal bovine serum, 1% Pen/
Strep mix and sodium pyruvate in a humidified atmosphere with
5% CO2 at 37uC. Cells were plated in either 6-well or 24-well
plates (for WB or luciferase assay, respectively), and transfected
with GeneJuice (Novagen). For luciferase assays, expression
vectors were used at different doses depending on the experiment.
Figure 5. In-situ hybridisation for Fbxl3 and Fbxl21 within the SCN of the sheep and mouse. A. Representative images for expression of
Fbxl21 (top), Fbxl3 and the neuropeptides, Avp and Vip (bottom) in the hypothalamus of sheep sampled at ZT4-6. Sense controls for Fbxl riboprobes
are also shown (top and middle right panels). B. Fbxl21 undergoes circadian expression in the SCN of the mouse. Top: mRNA profiles in the SCN of
mice sampled at 6 different time-points (n=5 per time-point) under either a 12/12 light-dark cycle (LD) or under constant darkness (DD). Data for ZT/
CT0 are double-plotted. Bottom: representative in-situ autoradiograms. Note the SCN-restricted pattern of expression. Two-way ANOVA: time-effect,
P,0.001, light condition6time interaction, p=0.39. C. Fbxl3 does not show circadian expression in the SCN of the mouse. Representative images for
expression of Fbxl3 in the brain of mouse sampled at ZT4 and ZT16. Note the ubiquitous pattern of labelling including diffuse expression in the SCN.
doi:10.1371/journal.pone.0003530.g005
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struct were used at 50 ng/well. Total transfected DNA amount
was set to an equal amount between all conditions by addition of
the corresponding empty vector. Luciferase assay was performed
on the day following transfection. Briefly, cells were rinsed twice in
cold PBS and lysed for 15 min in lysis buffer (25 mM Tris, 2 mM
EDTA, 1 mM DTT (dithiothreitol), 10% glycerol and 1% Triton
X-100). The luciferase assay was performed using a Luciferase
assay system kit (Promega) and a Lumicount microplate
luminometer (Packard). Results were normalised to b-galactosi-
dase activity. Data (in relative luminescence units) represent fold
induction once normalised to b-galactosidase. Experiments were
repeated three to five times, each condition in triplicate. For WB
experiments, variable amounts of DNA were transfected, never
exceeding 4 mg/well. Experiments were done at least in triplicate.
Western blot and immunoprecipitation
Cells were plated in 6-well plates and transfected as described
above. For protein synthesis inhibition experiments, 25 mg/ml
cycloheximide (CHX; Sigma) was added 24 h post-transfection for
8, 2 or 0 h prior to harvesting. Cells were rinsed twice in cold PBS,
resuspended in RIPA buffer (50 mMTris-HCl, pH 8, 150 mM
NaCl, 1% Nonidet P40, 0.5% Na-deoxycholate, 0.1% SDS,
0.5 mM DTT, 1 mM PMSF and a cocktail of protease inhibitors
(Complete Mini; Roche) and incubated for 30 min on ice. After
vortexing, the extract was centrifuged for 1 min at 16000 g and
supernatants used for Western blot (WB) or kept at 280uC. For
immunoprecipitation assay cells were harvested 48 h post-
transfection in IP buffer (150 mM NaCl, 5 mM EDTA, 0.5%
Nonidet P40, 50 mM Tris, pH 7.8, 1 mM PMSF and a cocktail of
protease inhibitors (Complete Mini; Roche). An aliquot of
supernatant was kept as input for western-blot analysis while the
rest was incubated overnight at 4uC with anti-Myc affinity resin
(Sigma) in IP buffer. The beads were then washed twice with IP
buffer, resuspended in Laemmli buffer (50 mM Tris/HCl pH 6.8,
2% SDS, 0.1% Bromophenol Blue, 10% glycerol and 100 mM
DTT), denatured at 95uC for 5 min and the supernatant was
resolved on a 6% or 12% SDS polyacrylamide gel. Nitrocellulose
membranes (Amersham) were then probed with antibodies
directed against Myc (Roche) or Flag (Sigma). Anti-mouse
horseradish peroxidase-conjugated antibody (Sigma) and the
ECLH (enhanced chemiluminescence) detection reagent (Amer-
sham) were used for revelation using Hyperfilm ECL (Amersham).
RT-PCR on tissues
RT-PCR was performed as described in the tissue collection and
cloning section. Co-amplification of an 879 bp fragment of oCKId
was used as a positive control. Omission of cDNA in the PCR mix
was used as a negative control. Initial screening for Fbxl3 was
performed using oligos O47C (GGGGTAATCTCCTTCAGG)
and O48C (CTAGGACTTTGAGCGAGG) yielding 471 and
327 nt PCR fragments for Fbxl3fl and Fbxl3sv, respectively.
Another PCR was performed using oligos O51C (GCAACTG-
GAACCAGGTGG) and O52C (GGAAGTGAGTCTGTCCT-
GG) yielding a 474 nt PCR product for Fbxl3sv only since O51C
spans the splicing junction (the sequence corresponding to O51C in
Fbxl3fl being GCAACTGGAACCAGGTAT prevents complete
hybidization of the oligo hence polymerisation). Confirming
specificity of the approach, no PCR product was obtained with
O51C/O52C when the Fbxl3fl expression vector was used as a
template while the expected 474 nt product was readily amplified
from the Fbxl3sv expression construct. PCR screening for Fbxl21
was performed using oligos O49C (CCATCTCCAGTATGT-
CAGC) and O50C (ATGCCAGTTCTCTCAGACC) yielding
386 and 298 nt PCR fragments for Fbxl21fl and Fbxl21sv,
respectively.
Figure 6. mFbxl21 is a clock-controlled gene. A. Schematics
depicting the promoter region of the mouse Fbxl21 gene, E’ indicate
non-canonical E-Box motifs, D-Box indicates a putative response
element for the PAR-bZIP proteins. B. The mouse Fbxl21 gene is
responsive to both CLK/BM1 and the PAR-bZIP transcription factors.
Transfection conditions per well: 50 ng of Fbxl21 promoter reporter,
50 ng of b-Gal reporter and either 100 ng of mClock+100 ng of mBmal1
or 100 ng of each of the PAR-bZIP transcription factors and/or
necessary amount of empty vector to make a final amount of 300 ng.
Data in A/B are mean6SEM of one triplicate representative from 3
replicate experiments. Different letters above bars indicate significantly
different groups (p,0.05).
doi:10.1371/journal.pone.0003530.g006
Figure 7. A model for Fbxl21 function in the mammalian
circadian clock. Transcriptional control (green dashed line) by CLK/
BM1 directs rhythmic expression of Cry1 and the PAR-bZIP and also has
a modest effect upon Fbxl21. Transcription of Fbxl21 mostly depends on
the PAR-bZIP proteins. The FBXL21 protein in turn controls degradation
of CRY1 (red diamond-ended line) and therefore exerts a pivotal role in
the control of CRY1-mediated inhibition of CLK/BM1 transcription (red
diamond-ended line).
doi:10.1371/journal.pone.0003530.g007
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Complete cds for the ovine arginine-vasopressin (Avp) and
vasoactive intestinal polypeptide (Vip) were cloned and deposited
in GenBank. Homologous probes used in this paper are as follows:
oFbxl3 covers nt 110–580 of EF643523, oFbxl21 covers nt 342–
709 of EU239380, oAvp covers nt 1–501 of EU045357, oVip
covers nt 1–513 of EU016225, mFbxl3 covers nt 450–1175 of
NM_015822, mFbxl21 covers nt 905–1656 of NM_178674.
Hypothalamic blocks for in situ hybridisation were cut into
20 mm sections using a cryostat, and thaw-mounted onto poly-
lysine and gelatin coated slides. Radioactive cRNA riboprobes
were prepared by plasmid linearisation and in vitro transcription
reactions including
35S-UTP (Perkin-Elmer). Sections were
hybridized overnight at 60uC with 5.10
5 cpm of probe per slide,
subjected to RNaseA digestion and stringency washes in sodium
citrate buffer to remove nonspecific probe hybridisation. Slides
were then dehydrated in graded ethanol solutions and exposed to
an autoradiographic film (Kodak) for 4 days.
Statistics
Data were analysed (Sigma-stat, Jandel Scientific) by one-way or
two-way ANOVA followed, when appropriate, by the Student-
Newman–Keuls post-hoc test. Significance was set at P,0.05.
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